194 related articles for article (PubMed ID: 22879203)
1. Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride.
Kristal AR; Till C; Tangen CM; Goodman PJ; Neuhouser ML; Stanczyk FZ; Chu LW; Patel SK; Thompson IM; Reichardt JK; Hoque A; Platz EA; Figg WD; Van Bokhoven A; Lippman SM; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1823-32. PubMed ID: 22879203
[TBL] [Abstract][Full Text] [Related]
2. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
Stanczyk FZ; Azen CG; Pike MC
J Steroid Biochem Mol Biol; 2013 Nov; 138():10-6. PubMed ID: 23474436
[TBL] [Abstract][Full Text] [Related]
3. Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.
Kristal AR; Schenk JM; Song Y; Arnold KB; Neuhouser ML; Goodman PJ; Lin DW; Stanczyk FZ; Thompson IM
Am J Epidemiol; 2008 Dec; 168(12):1416-24. PubMed ID: 18945688
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of sex hormone levels and risk of prostate cancer.
Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
[TBL] [Abstract][Full Text] [Related]
5. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen.
Schwartz JI; Tanaka WK; Wang DZ; Ebel DL; Geissler LA; Dallob A; Hafkin B; Gertz BJ
J Clin Endocrinol Metab; 1997 May; 82(5):1373-7. PubMed ID: 9141518
[TBL] [Abstract][Full Text] [Related]
6. Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations.
Cook MB; Stanczyk FZ; Wood SN; Pfeiffer RM; Hafi M; Veneroso CC; Lynch B; Falk RT; Zhou CK; Niwa S; Emanuel E; Gao YT; Hemstreet GP; Zolfghari L; Carroll PR; Manyak MJ; Sesterhann IA; Levine PH; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1660-1666. PubMed ID: 28830872
[No Abstract] [Full Text] [Related]
7. Association of SRD5A2 variants and serum androstane-3alpha,17beta-diol glucuronide concentration in Chinese elderly men.
Jiang J; Tang NL; Ohlsson C; Eriksson AL; Vandenput L; Liao C; Wang X; Chan FW; Kwok A; Orwoll E; Kwok TC; Woo J; Leung PC
Clin Chem; 2010 Nov; 56(11):1742-9. PubMed ID: 20855474
[TBL] [Abstract][Full Text] [Related]
8. Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?
Kalogera E; Pistos C; Provatopoulou X; Athanaselis S; Spiliopoulou C; Gounaris A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():24-34. PubMed ID: 24140653
[TBL] [Abstract][Full Text] [Related]
9. Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.
Yao S; Till C; Kristal AR; Goodman PJ; Hsing AW; Tangen CM; Platz EA; Stanczyk FZ; Reichardt JK; Tang L; Neuhouser ML; Santella RM; Figg WD; Price DK; Parnes HL; Lippman SM; Thompson IM; Ambrosone CB; Hoque A
Cancer Causes Control; 2011 Aug; 22(8):1121-31. PubMed ID: 21667068
[TBL] [Abstract][Full Text] [Related]
10. Hormone blood levels and their inter-relationships in normal men and men with benign prostatic hyperplasia (BPH).
Bartsch W; Becker H; Pinkenburg FA; Krieg M
Acta Endocrinol (Copenh); 1979 Apr; 90(4):727-36. PubMed ID: 86267
[TBL] [Abstract][Full Text] [Related]
11. Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry.
Hsing AW; Stanczyk FZ; Bélanger A; Schroeder P; Chang L; Falk RT; Fears TR
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1004-8. PubMed ID: 17507629
[TBL] [Abstract][Full Text] [Related]
12. Decrease in lean body mass in men with prostate cancer receiving androgen deprivation therapy: mechanism and biomarkers.
Hara N; Ishizaki F; Saito T; Nishiyama T; Kawasaki T; Takahashi K
Urology; 2013 Feb; 81(2):376-80. PubMed ID: 23374809
[TBL] [Abstract][Full Text] [Related]
13. Trends in sex hormone concentrations in US males: 1988-1991 to 1999-2004.
Nyante SJ; Graubard BI; Li Y; McQuillan GM; Platz EA; Rohrmann S; Bradwin G; McGlynn KA
Int J Androl; 2012 Jun; 35(3):456-66. PubMed ID: 22150314
[TBL] [Abstract][Full Text] [Related]
14. Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial.
Schenk JM; Till C; Hsing AW; Stanczyk FZ; Gong Z; Neuhouser ML; Reichardt JK; Hoque AM; Figg WD; Goodman PJ; Tangen CM; Thompson IM
Cancer Causes Control; 2016 Feb; 27(2):175-82. PubMed ID: 26589415
[TBL] [Abstract][Full Text] [Related]
15. Effects of testosterone metabolites on serum gonadotropin concentrations in immature male rats.
Moger WH
Can J Physiol Pharmacol; 1975 Oct; 53(5):839-44. PubMed ID: 1201489
[TBL] [Abstract][Full Text] [Related]
16. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
Yang Q; Titus MA; Fung KM; Lin HK
J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
[TBL] [Abstract][Full Text] [Related]
17. Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3alpha-androstanediol and 17beta-estradiol.
Reddy DS
Neuroscience; 2004; 129(1):195-207. PubMed ID: 15489042
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Habib FK; Ross M; Tate R; Chisholm GD
Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
[TBL] [Abstract][Full Text] [Related]
19. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.
; Roddam AW; Allen NE; Appleby P; Key TJ
J Natl Cancer Inst; 2008 Feb; 100(3):170-83. PubMed ID: 18230794
[TBL] [Abstract][Full Text] [Related]
20. Radical prostatectomy: influence on serum and urinary androgen levels.
Olsson M; Ekström L; Schulze J; Kjellman A; Akre O; Rane A; Gustafsson O
Prostate; 2010 Feb; 70(2):200-5. PubMed ID: 19760638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
